Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Neurobiol Dis. 2014 Mar 13;67:191–202. doi: 10.1016/j.nbd.2014.03.004

Figure 7. Changes in adenosine A2A receptor expression in MPTP-treated mice.

Figure 7

CX3CR1GFP/+ mice were treated with 20 mg/kg s.c. MPTP or saline once daily for 5 days, and brains were isolated for analysis 5 days later. A, Adenosine A2A receptor expression in the substantia nigra was detected with immunofluorescence. Microglia were identified without staining from the expression of GFP from the CX3CR1 promoter. Approximate borders between SNc and SNr are given with dashed lines based on microglial cell density. Scale bar: 30 μm. B, Adenosine A2A receptor expression in the substantia nigra as detected with DAB precipitation. Scale bar: 200 μm. C, Upregulation of A2A receptor expression in the SNr following MPTP treatment was quantified by measuring the average Texas Red fluorescence signal. D, For comparison, the A2A receptor signal in the striatum is shown. Even after upregulation in the SN, A2A receptor is not expressed at the levels of the striatum. Scale bar: 30 μm. E, Quantification of A2A receptor expression in the striatum following MPTP treatment by measuring the average Texas Red fluorescence signal. Statistics: two-tailed Student’s t test. *, p < 0.05.